New approvals — United Kingdom

MHRA medicines recalls and defect notifications with batch numbers, Serious Shortage Protocols, new approvals and Drug Safety Update — updated daily, automatically. Last updated: 6 Nov 2026 08:50.

All Recalls and defects6 Serious shortages (SSP) New approvals4 Drug Safety Update4

Sources: we track changes based on information published by the MHRA — medicines recalls and defect notifications, Drug Safety Update and approval announcements — and the Serious Shortage Protocols published by the NHS Business Services Authority. The UK is outside the EU, so European Commission decisions are not listed here.

30 Oct 2026Friday 30 October 2026 · 8 days ago

1 event

MHRA approval gene-editing treatment

Children aged five and over with severe sickle-cell disease and transfusion-dependent β-thalassemia, can now be treated with Casgevy (exagamglogene autotemcel), following an extension of its UK author…

What this means, batches, details

Loading…

details and permanent link MHRA announcement ↗ MHRA — Medicines and Healthcare products Regulatory Agency

In total 1 event on this day.

Key

class 1 recall (risk to life)

class 2–3 recall, serious shortage, safety update

class 4 defect notification, new approval

A batch recall does not mean the medicine is withdrawn: it remains licensed, only the listed batches are affected.

Sources

MHRA alerts — medicines recalls and defect notifications since January 2024.
Drug Safety Update.
Serious Shortage Protocols (NHSBSA).